Abstract:Background Ganoderma lucidum is a basidiomycete white rot fungus and is of medicinal importance in China, Japan and other countries in the Asiatic region. To date, much research has been performed in identifying the medicinal ingredients in Ganoderma lucidum. Despite its important therapeutic effects in disease, little is known about Ganoderma lucidum at the genomic level. In order to gain a molecular understanding of this fungus, we utilized Illumina high-throughput technology to sequence and analyze the transcriptome of Ganoderma lucidum. Methodology/Principal Findings We obtained 6,439,690 and 6,416,670 high-quality reads from the mycelium and fruiting body of Ganoderma lucidum, and these were assembled to form 18,892 and 27,408 unigenes, respectively. A similarity search was performed against the NCBI non-redundant nucleotide database and a customized database composed of five fungal genomes. 11,098 and 8, 775 unigenes were matched to the NCBI non-redundant nucleotide database and our customized database, respectively. All unigenes were subjected to annotation by Gene Ontology, Eukaryotic Orthologous Group terms and Kyoto Encyclopedia of Genes and Genomes. Differentially expressed genes from the Ganoderma lucidum mycelium and fruiting body stage were analyzed, resulting in the identification of 13 unigenes which are involved in the terpenoid backbone biosynthesis pathway. Quantitative real-time PCR was used to confirm the expression levels of these unigenes. Ganoderma lucidum was also studied for wood degrading activity and a total of 22 putative FOLymes (fungal oxidative lignin enzymes) and 120 CAZymes (carbohydrate-active enzymes) were predicted from our Ganoderma lucidum transcriptome. Conclusions Our study provides comprehensive gene expression information on Ganoderma lucidum at the transcriptional level, which will form the foundation for functional genomics studies in this fungus. The use of Illumina sequencing technology has made de novo transcriptome assembly and gene expression analysis possible in species that lack full genome information.

Ganoderma Lucidum: an Emerging Medicinal Model Fungus for Study of the Biosynthesis of Natural Medicines

Identification of a Novel Metabolic Target for Bioactive Triterpenoids Biosynthesis in <i>Ganoderma</i> lucidum

Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum

Comparative genome and transcriptome analysis reveal the medicinal basis and environmental adaptation of artificially cultivated Taiwanofungus camphoratus

From Taxonomy and Industry to Genetics: Fungal Biology in China.

Determination of compounds in mycelium of Ganoderma lucidum in submerged fermentation

Shedding Light on the Mechanisms Underlying the Environmental Regulation of Secondary Metabolite Ganoderic Acid in Ganoderma Lucidum Using Physiological and Genetic Methods.

Germplasm resources and secondary metabolism regulation in Reishi mushroom <i>(Ganoderma lucidum)</i>

Deep Insight into the Ganoderma Lucidum by Comprehensive Analysis of Its Transcriptome

Research strategy for model medicinal species

Germplasm resources and secondary metabolism regulation in Reishi mushroom (Ganoderma lucidum)

Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction.

The Genome Of Ganderma Lucidum Provide Insights Into Triterpense Biosynthesis And Wood Degradation

Ganoderma lucidum: A Potent Pharmacological Macrofungus

Transcriptome and metabolome analyses reveal transcription factors regulating ganoderic acid biosynthesis in Ganoderma lucidum development

Development of a Simple and Efficient Transformation System for the Basidiomycetous Medicinal Fungus Ganoderma Lucidum

Chromosome-level Genome Map Provides Insights into Diverse Defense Mechanisms in the Medicinal Fungus Ganoderma Sinense

Changes of Active Substances in Ganoderma lucidum during Different Growth Periods and Analysis of Their Molecular Mechanism

Enhancement of ganoderic acid accumulation by overexpression of an N-terminally truncated 3-hydroxy-3-methylglutaryl coenzyme A reductase gene in the basidiomycete Ganoderma lucidum

Complete Mitochondrial Genome Of The Medicinal Mushroom Ganoderma Lucidum